Clinical Trial Update: Erythropoietin and Platelet Activation Markers [Phase 4]

View source ↗

Summary

Phase 4 clinical trial at the Medical University of Vienna studied erythropoietin and platelet activation markers in patients with thrombosis and hypertension. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Thrombosis

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Medical University of Vienna | Conditions: Thrombosis, Hypertension | Phase 4 | Status: COMPLETED